Icahn School of Medicine at Mount Sinai /ID# 269529 — New York, New York

Icahn School of Medicine at Mount Sinai /ID# 269529 is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Icahn School of Medicine at Mount Sinai /ID# 269529 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine at Mount Sinai /ID# 269529?

Icahn School of Medicine at Mount Sinai /ID# 269529 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine at Mount Sinai /ID# 269529 conducted?

Icahn School of Medicine at Mount Sinai /ID# 269529 has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Is Icahn School of Medicine at Mount Sinai /ID# 269529 accredited by Crixeo Health?

Icahn School of Medicine at Mount Sinai /ID# 269529 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icahn School of Medicine at Mount Sinai /ID# 269529?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.